Interferon antibodies may negate the antiviral effects of recombinant alpha-interferon treatment in patients with chronic hepatitis B virus infection (Q45849818)

From Wikidata

Jump to navigation Jump to search

scientific article published in December 1990

Language	Label	Description	Also known as
English	Interferon antibodies may negate the antiviral effects of recombinant alpha-interferon treatment in patients with chronic hepatitis B virus infection	scientific article published in December 1990

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/2258142

Interferon antibodies may negate the antiviral effects of recombinant alpha-interferon treatment in patients with chronic hepatitis B virus infection (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/2258142

1 reference

based on heuristic

inferred from title

Hepatitis B virus

1 reference

based on heuristic

inferred from title

chronic hepatitis B

1 reference

based on heuristic

inferred from title

chronic hepatitis

1 reference

based on heuristic

inferred from title

author name string

A S Lok

1

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/2258142

C L Lai

2

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/2258142

E K Leung

3

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/2258142

language of work or name

0 references

publication date

1 December 1990

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/2258142

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/2258142

12

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/2258142

6

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/2258142

1266-1270

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/2258142

Antiviral Treatment of Chronic Hepatitis B Virus Infection. I. Changes in Viral Markers with Interferon Combined with Adenine Arabinoside

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120603

21 January 2018

Recombinant Leukocyte A Interferon: Pharmacokinetics, Single-Dose Tolerance, and Biologic Effects in Cancer Patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120603

21 January 2018

A randomized study of the effects of adenine arabinoside 5'-monophosphate (short or long courses) and lymphoblastoid interferon on hepatitis B virus replication.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120603

7 January 2021

based on heuristic

inferred from DOI database lookup

Loss of HBsAg with interferon therapy in chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120603

7 January 2021

based on heuristic

inferred from DOI database lookup

Lymphoblastoid interferon therapy of chronic HBV infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120603

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized, controlled trial of recombinant human alpha-interferon in patients with chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120603

7 January 2021

based on heuristic

inferred from DOI database lookup

LONG-TERM FOLLOW-UP IN A RANDOMISED CONTROLLED TRIAL OF RECOMBINANT α2-INTERFERON IN CHINESE PATIENTS WITH CHRONIC HEPATITIS B INFECTION

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120603

7 January 2021

based on heuristic

inferred from DOI database lookup

PLACEBO-CONTROLLED TRIAL OF RECOMBINANT α2-INTERFERON IN CHINESE HBsAg-CARRIER CHILDREN

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120603

7 January 2021

based on heuristic

inferred from DOI database lookup

A longitudinal follow-up of asymptomatic hepatitis B surface antigen-positive chinese children

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120603

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute exacerbations in Chinese patients with chronic hepatitis B virus (HBV) infection. Incidence, predisposing factors and etiology

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120603

7 January 2021

based on heuristic

inferred from DOI database lookup

Interferon-neutralizing antibodies in a patient treated with human fibroblast interferon

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120603

7 January 2021

based on heuristic

inferred from DOI database lookup

Low incidence of serum neutralizing factors in patients receiving recombinant alfa-2b interferon (Intron A)

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120603

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical significance of anti-IFN-alpha antibody titres during interferon therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120603

7 January 2021

based on heuristic

inferred from DOI database lookup

Antitumor activity of recombinant-derived interferon alpha in metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120603

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibodies to human leucocyte interferons in cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120603

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence and clinical significance of neutralizing antibodies in patients receiving recombinant interferon alfa-2a by intramuscular injection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120603

7 January 2021

based on heuristic

inferred from DOI database lookup

Resistance to Recombinant Interferon Alfa-2a in Hairy-Cell Leukemia Associated with Neutralizing Anti-Interferon Antibodies

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120603

7 January 2021

based on heuristic

inferred from DOI database lookup

Interferon antibodies in patients with chronic HBV infection treated with recombinant interferon

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120603

7 January 2021

based on heuristic

inferred from DOI database lookup

The detection of antibodies to recombinant interferon alfa-2a in human serum

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120603

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantitation of neutralization of interferon by antibody

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120603

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HEP.1840120603

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/2258142

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/2258142

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45849818&oldid=2086277211"